Craneware plc (LON:CRW - Get Free Report) shares crossed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 2,234.26 ($28.09) and traded as high as GBX 2,300 ($28.92). Craneware shares last traded at GBX 2,260 ($28.41), with a volume of 32,939 shares trading hands.
Wall Street Analyst Weigh In
Several research analysts recently commented on CRW shares. Berenberg Bank reaffirmed a "buy" rating and issued a GBX 2,700 ($33.95) target price on shares of Craneware in a research report on Tuesday, September 3rd. Shore Capital reaffirmed a "buy" rating on shares of Craneware in a report on Tuesday, December 10th.
Read Our Latest Report on Craneware
Craneware Price Performance
The stock has a market capitalization of £791.62 million, a P/E ratio of 8,692.31 and a beta of 0.28. The company has a current ratio of 0.63, a quick ratio of 1.00 and a debt-to-equity ratio of 12.22. The company has a fifty day simple moving average of GBX 2,136.80 and a two-hundred day simple moving average of GBX 2,234.26.
Craneware Company Profile
(
Get Free Report)
Craneware plc, together with its subsidiaries, develops, licenses, and supports computer software for the healthcare industry in the United States. The company provides solutions, such as Trisus pricing transparency software; Trisus Pricing Analyzer, a solution that simplifies and automates the price modeling process; Trisus Chargemaster, an automated chargemaster management solution; InSight Medical Necessity, a solution that offers medical necessity for the United States payors; Trisus Claims Informatics, a retrospective charge capture analytical application that identifies areas of risk for its team to investigate; Trisus Supply, a solution that improves supplies reimbursement; and InSight Audit, an audit management solution for government and commercial payors.
See Also
Before you consider Craneware, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Craneware wasn't on the list.
While Craneware currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link below to learn more about using beta to protect yourself.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
